A new weight loss drug has been rejected by the FDA because of numerous concerns about side-effects and limited efficacy. …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

